FDA Drug Application (020622) for COPAXONE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number020622
Product Number001
FormFOR SOLUTION;SUBCUTANEOUS
Dosage20MG/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCOPAXONE
Active IngredientGLATIRAMER ACETATE

Active IngredientCount
List of drugs with Active Ingredient GLATIRAMER ACETATE2


Back to FDA Applications sponsored by TEVA PHARMS USA